125 related articles for article (PubMed ID: 1824666)
1. Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: an ex vivo study.
Hernandez Hernandez R; Guerrero Pajuelo JR; Carvajal AR; Armas Padilla MC; Armas de Hernandez MJ; Barragan O; Boada Boada JJ
Am Heart J; 1991 Jan; 121(1 Pt 2):395-401. PubMed ID: 1824666
[TBL] [Abstract][Full Text] [Related]
2. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
3. The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study.
Hernandez Hernandez R; Carvajal AR; Guerrero Pajuelo J; Armas de Hernandez MJ; Armas Padilla MC; Barragan O; Boada Boada JJ; Roa E
Am Heart J; 1991 Jan; 121(1 Pt 2):389-94. PubMed ID: 1824665
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol.
Taylor SH
Am Heart J; 1991 Jan; 121(1 Pt 2):362-6. PubMed ID: 1824662
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparative study of doxazosin and prazosin when administered with beta-blockers or diuretics.
de Planque BA
Am Heart J; 1991 Jan; 121(1 Pt 2):304-11. PubMed ID: 1670744
[TBL] [Abstract][Full Text] [Related]
6. Control of coronary heart disease risk factors with doxazosin as monotherapy and in combination therapy.
Rosenthal J
Am Heart J; 1988 Dec; 116(6 Pt 2):1763-6. PubMed ID: 2904747
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with doxazosin in general medical practice in The Netherlands.
Harmse DP
Am Heart J; 1991 Jan; 121(1 Pt 2):341-5. PubMed ID: 1824658
[TBL] [Abstract][Full Text] [Related]
8. Doxazosin in the treatment of essential hypertension in general medical practice in Latin America.
Silva H; Fonseca R; Marshall D
Am Heart J; 1991 Jan; 121(1 Pt 2):329-35. PubMed ID: 1824656
[TBL] [Abstract][Full Text] [Related]
9. A long-term study of doxazosin in the treatment of mild or moderate essential hypertension in general medical practice.
Manos J
Am Heart J; 1991 Jan; 121(1 Pt 2):346-51. PubMed ID: 1824659
[TBL] [Abstract][Full Text] [Related]
10. An open, noncomparative study of doxazosin in essential hypertension: experience in general practice in The Netherlands.
Naber FB
Am Heart J; 1991 Jan; 121(1 Pt 2):273-9. PubMed ID: 1824650
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Talseth T; Westlie L; Daae L; Vatle S
Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
[TBL] [Abstract][Full Text] [Related]
12. Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up.
Talseth T; Westlie L; Daae L
Am Heart J; 1991 Jan; 121(1 Pt 2):280-5. PubMed ID: 1824651
[TBL] [Abstract][Full Text] [Related]
13. The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by beta-blockers.
Englert RG; Barlage U
Am Heart J; 1991 Jan; 121(1 Pt 2):311-6. PubMed ID: 1670745
[TBL] [Abstract][Full Text] [Related]
14. A multicenter study of doxazosin in the treatment of essential hypertension in France.
Bonnet G
Am Heart J; 1991 Jan; 121(1 Pt 2):335-40. PubMed ID: 1824657
[TBL] [Abstract][Full Text] [Related]
15. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
Englert RG; Mauersberger H
Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
[TBL] [Abstract][Full Text] [Related]
16. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
[TBL] [Abstract][Full Text] [Related]
17. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
Searle M; Dathan R; Dean S; Christensen CC; Westheim A
Eur J Clin Pharmacol; 1990; 39(3):299-300. PubMed ID: 2147909
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with doxazosin in general medical practice.
Rosenthal J
Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
[TBL] [Abstract][Full Text] [Related]
19. Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice.
van den Hogen AL
Am Heart J; 1988 Dec; 116(6 Pt 2):1757-62. PubMed ID: 2904746
[TBL] [Abstract][Full Text] [Related]
20. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.
Pool JL
Am Heart J; 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60. PubMed ID: 1824647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
